Free Trial

Synthomer (LON:SYNT) Shares Pass Below Two Hundred Day Moving Average - Here's Why

Synthomer logo with Basic Materials background

Synthomer plc (LON:SYNT - Get Free Report)'s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 114.73 ($1.55) and traded as low as GBX 97.50 ($1.32). Synthomer shares last traded at GBX 99.50 ($1.34), with a volume of 281,270 shares.

Synthomer Price Performance

The company has a current ratio of 1.90, a quick ratio of 0.97 and a debt-to-equity ratio of 78.27. The stock has a market capitalization of £158.07 million, a PE ratio of -1.93, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The firm has a 50 day moving average price of GBX 104.24 and a 200 day moving average price of GBX 113.78.

Insider Buying and Selling

In other news, insider Janet E. Ashdown bought 19,920 shares of Synthomer stock in a transaction that occurred on Thursday, July 3rd. The stock was bought at an average cost of GBX 99 ($1.34) per share, with a total value of £19,720.80 ($26,638.93). 28.00% of the stock is currently owned by insiders.

About Synthomer

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

See Also

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines